The Cerebrum® The Cerebrum DX® gene tests for neurological disorders are a set of thorough, clinically validated, extremely sensitive, and specific multi-gene assays..
Cordis DX®
Cordis DX® A set of multi-gene assays with high sensitivity and specificity that have been clinically tested, Cordis DX® examines the genes linked to cardiovascular disorders, including: Arrhythmias Hypertrophic cardiomyopathy (HCM), distense cardiomyopathy (DCM), restrictive cardiomyopathy (RCM), and LVNC are examples of cardiomyopathies.
BRCA Germline
For the detection of inherited mutations in the breast and ovarian cancer
Colon AiQ
Colon AiQ provides an alternative screening option for individuals who delay undergoing a colonoscopy. Using advanced molecular biology, it helps detect whether there’s an urgent need for a colonoscopy
RediScore®
The RediScore® test is largely suggested for all patients with ovarian cancer, as well as in cases where PARP inhibitor therapy is being explored for treatment or maintenance.
The FRα
FRα: Novel Assessment for Targeted Treatment of Ovarian Carcinoma
Gliogene®
The GlioGene® test is advised for all patients diagnosed with gliomas, irrespective of type, grade, or age.
Com.Pl.it DX® Liquid
Liquid biopsy multigene assay to determine an optimal treatment strategy for each solid tumor.
Programmed Death-Ligand 1
The PD-L1 test assists physicians in assessing a patient’s potential benefit from immunotherapy, particularly in non-small cell lung cancer (NSCLC), gastric adenocarcinomas, gastroesophageal sphincter adenocarcinomas, urinary tract cancers, and various other malignancies.



